Racial and ethnic differences in topography and subjective effects among young adults in response to smoking their usual brand menthol or nonmenthol cigarette.
Experimental and Clinical Psychopharmacology · 2025
DOI: 10.1037/pha0000765 ↗At a glance
Journal article in Experimental and Clinical Psychopharmacology, 2025. Written by Amy M Cohn and 11 co-authors. Institution: Department of Pediatrics, University of Oklahoma Health Sciences Center. Major MEDLINE topics: Menthol, Craving, Tobacco Products, Cigarette Smoking. The full text is freely available in PubMed Central. Funded by: University of Oklahoma; Health Sciences Center, NIDA NIH HHS, Oklahoma Tobacco Settlement Endowment Trust.
Abstract (original language)
= 23.9; 49.5% menthol; 37.2% non-White) following ≥12 hr of abstinence. Participants smoked their usual brand cigarette (menthol or nonmenthol) in a single laboratory session. Differences in study outcomes were examined across cigarette flavor and by race/ethnicity (White vs. non-White). No main effects of cigarette flavor or race/ethnicity emerged on any study outcomes. Interactions of cigarette flavor with race/ethnicity emerged on postsmoking craving and cigarette weight, controlling for presmoking measures of the outcome and cigarettes per day. Compared to non-White participants who smoked nonmenthol cigarettes, non-White participants who smoked menthol cigarettes had higher postsmoking cigarette weight and lower postsmoking craving. Further, non-White participants who smoked menthol cigarettes had lower postsmoking craving compared to White participants who smoked menthol cigarettes. Non-White young adults who smoke menthols experienced greater craving reduction, despite consuming less of their preferred cigarette. Craving reduction may be one mechanism fostering continued menthol smoking. Menthol smoking, even at lower amounts, produces similar toxicant exposure, which may contribute to tobacco health disparities as smoking progresses. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Pediatrics, University of Oklahoma Health Sciences Center.
- Battelle Memorial Institute.
- Department of Public Health Sciences, University of Chicago.
- Department of Psychology, University of Memphis.
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania.
- Department of Health Behavior, Society, and Policy, Rutgers School of Public Health, Rutgers Institute for Nicotine and Tobacco Studies.
ORCID profiles: Amy M Cohn
Funding
- University of Oklahoma; Health Sciences Center
- NIDA NIH HHS
- Oklahoma Tobacco Settlement Endowment Trust
- National Institutes of Health; National Institute on Drug Abuse
- NIEHS NIH HHS
- National Institutes of Health
- University of Oklahoma
- Sponsor name not included
Cite
APA
Cohn, A. M., Elmasry, H., Niznik, T., Pickworth, W., Smith, M. A., Margaritis, W. D., Wyatt, R., Dunn, D., Hedeker, D., Murphy, J., Audrain-McGovern, J., & Villanti, A. C. (2025). Racial and ethnic differences in topography and subjective effects among young adults in response to smoking their usual brand menthol or nonmenthol cigarette. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000765
Vancouver
Cohn AM, Elmasry H, Niznik T, Pickworth W, Smith MA, Margaritis WD, et al. Racial and ethnic differences in topography and subjective effects among young adults in response to smoking their usual brand menthol or nonmenthol cigarette. Experimental and Clinical Psychopharmacology. 2025. doi:10.1037/pha0000765
BibTeX
@article{Cohn2025,
author = {Cohn, Amy M and Elmasry, Hoda and Niznik, Taylor and Pickworth, Wallace and Smith, Michael A and Margaritis, Whitney D and Wyatt, Riley and Dunn, Delaney and Hedeker, Donald and Murphy, James and Audrain-McGovern, Janet and Villanti, Andrea C},
title = {Racial and ethnic differences in topography and subjective effects among young adults in response to smoking their usual brand menthol or nonmenthol cigarette},
journal = {Experimental and Clinical Psychopharmacology},
year = {2025},
doi = {10.1037/pha0000765}
}
EUVIMED